ToxTracker is an in vitro method that accurately predicts genotoxicity without the use of animals. The results constitute an essential part of the approval process by the OECD for international acceptance of novel methods by regulatory authorities.
The evaluation was finalized earlier in the year and data have been submitted to the OECD showing that ToxTracker consistently demonstrates high accuracy and excellent reproducibility of test results, both within and between different laboratories. These data prove that ToxTracker is both robust and reliable. Importantly, ToxTracker can provide insight into the mode of action of genotoxic compounds thereby significantly improving the in vitro safety assessment of novel pharmaceutical products, chemicals, cosmetics and food-related products.
Visit the page below for the full press release and a link to the publication:
Toxys publication on OECD ring trial validation of ToxTracker
How can we slow down atherosclerosis? Researcher Amanda Foks believes it may be possible by targeting aged immune cells. This could lead to an entirely new treatment for heart...
Clinical Technology, the joint bachelor’s program offered by Erasmus MC, TU Delft, and LUMC, has once again received the “Top Program” designation from the Keuzegids...
Scientists have successfully tested a new medication that could represent a breakthrough in the treatment of heart disease. Researchers at Leiden University Medical Center (LUMC)...